Farmas USA

Abbott Labs. Resultados

https://seekingalpha.com/article/4337975-biocrysts-galidesivir-promising-candidate-drug-in-race-to-covidminus-19-treatment

 • Thinly traded cancer therapy developer Arcus Biosciences (RCUS+83.7%) is up big on almost a 7x surge in volume on reports that Gilead Sciences (GILD +2.0%) is mulling a "significant stake" in the company. 

• The company's pipeline includes anti-TIGIT antibody AB154, PD-1 inhibitor zimberelimab and dual A2a/A2b adenosine receptor antagonist AB928. 

• Alphabet's venture capital unit, GV, is also an investor.

MRNA con el empujón de hoy ya pasa los $40 

Parece que eso del Open Interest  y el vencimiento de opciones funciona.
BCRX

Bcrx
Animada AH, tocando los 3,20. No encuentro noticias.

 

 STAT reports that preliminary results from a study in Chicago evaluating Gilead Sciences' (NASDAQ:GILD) remdesivir in severely ill COVID-19 patients are positive with rapid recoveries in fever and respiratory symptoms observed and almost all patients discharged in less than a week.

 https://seekingalpha.com/news/3561503-gilead-up-6-after-hours-on-remdesivir-buzz-in-covidminus-19 

MRNA

483 millones para MODERNA del Barda.
 https://ih.advfn.com/stock-market/NASDAQ/moderna-MRNA/stock-news/82248221/moderna-announces-award-from-u-s-government-agenc